S26 - Neuro-opthalmology/Neuro-otology

Event Time: Tuesday April 25, 2017 3:30 pm to 5:30 pm
Topic(s): Neuro-ophthalmology/Neuro-otology
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:30 PM 001 Overdiagnosis of optic neuritis. Leanne Stunkel, MD
Disclosure:
Dr. Stunkel has nothing to disclose.

3:42 PM 002 Sensory prosthetics - clinical and scientific utility of a vestibular implant Csilla Haburcakova
Disclosure:
Dr. Haburcakova has nothing to disclose.

3:54 PM 003 Ischemic Optic Neuropathy in Cardiac Surgery: Incidence and Risk Factors in the United States from the Nationwide Inpatient Sample 1998-2013 Heather Moss, MD, PhD, FAAN
Disclosure:
Dr. Moss has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with legal firms.

4:06 PM 004 Gene Therapy for LHON : Low and Medium Dose Results John Guy, MD
Disclosure:
Dr. Guy has nothing to disclose.

4:18 PM 005 Intravitreal rAAV2/2-ND4 (GS010): A gene therapy for vision loss in Leber′s Hereditary Optic Neuropathy (LHON) caused by the G11778A ND4 mitochondrial mutation Scott Uretsky, MD
Disclosure:
Dr. Uretsky has received personal compensation for activities with GenSight Biologics as an employee. Dr. Uretsky holds stock and/or stock options in GenSight Biologics.

4:30 PM 006 Jun and Ddit3 (CHOP) deficiency provides additive protection for retinal ganglion cell death after optic nerve injury Stephanie Syc
Disclosure:
Dr. Syc has nothing to disclose.

4:42 PM 007 Does the Combination of Acute Hearing Loss and Vertigo Increase Stroke Risk? Tzu-Pu Chang
Disclosure:
Dr. Chang has nothing to disclose.

4:54 PM 008 Visual Fixation Instability for Evaluating Multiple Sclerosis Using OCT-Based Quantification of Retinal Movements Robert Mallery, MD
Disclosure:
Dr. Mallery has nothing to disclose.

Register Now

Related Courses